document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size font family time roman align center license agreement style margin margin bottom font size font family time roman align center between style margin margin bottom font size font family time roman align center dicerna pharmaceutical style margin margin bottom font size font family time roman align center hand style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center protiva biotherapeutics style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center tekmira pharmaceutical corporation style margin margin bottom font size font family time roman align center other hand style margin margin bottom font size font family time roman align center dated november nbsp style margin margin bottom font size font family time roman company requested order from security exchange commission commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom font size font family time roman align center table content style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign bottom nbsp valign bottom nbsp nbsp nbsp nbsp valign bottom nbsp valign bottom nbsp nbsp valign bottom colspan align center page valign bottom nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article nbsp nbsp nbsp definition valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman general valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman interpretation valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article nbsp license grant related right valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman license grant dicerna valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman sublicensing valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman grant back valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman retained right valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman right bankruptcy valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman contractor valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article financial provision valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman upfront payment milestone payment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman royalty payment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman royalty report expense report record audit valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman payment procedure valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman term payment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article nbsp additional obligation valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman obligation protiva valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman obligation dicerna valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman other obligation agreement party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article nbsp intellectual property valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman ownership valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman prosecution maintenance patent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman third party infringement protiva patent tekmira patent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman defense claim brought third party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article nbsp confidential information publicity valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman limitation disclosure valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman disclosure confidential information valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman exception valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman permitted protection valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center table content style margin margin bottom font size font family time roman align center continued style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign bottom nbsp valign bottom nbsp nbsp nbsp nbsp valign bottom nbsp valign bottom nbsp nbsp valign bottom colspan align center page valign bottom nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman permitted disclosure valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman press release valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article indemnification insurance valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman protiva indemnification valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman dicerna indemnification valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman tender defense counsel valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman insurance valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article nbsp viii term termination valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman term valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman termination material breach valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman termination failure actively develop commercialize valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman challenge protiva patent tekmira patent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman right bankruptcy valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman consequence termination survival valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman remedy valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article miscellaneous valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman representation warranty valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman force majeure valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman consequential damage valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman assignment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman notice valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman independent contractor valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman governing dispute resolution arbitration valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman severability valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman implied waiver valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman heading valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman entire agreement amendment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman waiver rule construction valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman third party beneficiary valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center table content style margin margin bottom font size font family time roman align center continued style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign bottom nbsp valign bottom nbsp nbsp nbsp nbsp valign bottom nbsp valign bottom nbsp nbsp valign bottom colspan align center page valign bottom nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman further assurance valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman performance affiliate valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin left text indent font size font family time roman counterpart valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center license agreement style margin margin bottom text indent font size font family time roman this license agreement this agreement entered into november nbsp effective date between dicerna pharmaceutical delaware corporation with office arsenal street building suite watertown affiliate dicerna hand protiva biotherapeutics british columbia corporation with principal place business font style white space nowrap nbsp glenlyon font parkway burnaby canada protiva tekmira pharmaceutical corporation british columbia corporation with principal place business font style white space nowrap nbsp glenlyon font parkway burnaby canada tekmira other hand style margin margin bottom font size font family time roman align center recital style margin margin bottom text indent font size font family time roman whereas protiva affiliate defined below posse develop improve from time time protiva patent technology each defined below style margin margin bottom text indent font size font family time roman whereas dicerna posse develops improves from time time intellectual property relating dicerna material defined below style margin margin bottom text indent font size font family time roman whereas pursuant material transfer agreement dated august nbsp among dicerna protiva tekmira party performed certain study order determine potential utility licensed intellectual property defined below relates product defined below basis this agreement with intent provide further study activity formulate develop regulatory approval commercialize more product style margin margin bottom text indent font size font family time roman whereas party contemporaneously herewith entering into supply agreement pursuant which protiva shall manufacture supply dicerna product certain purpose accordance with term forth therein style margin margin bottom text indent font size font family time roman whereas protiva desire grant dicerna license protiva intellectual property defined below develop manufacture commercialize each defined below product directed treatment upon term subject condition forth this agreement style margin margin bottom text indent font size font family time roman whereas tekmira desire grant dicerna license tekmira patent defined below develop manufacture commercialize product directed treatment upon term subject condition forth this agreement style margin margin bottom text indent font size font family time roman whereas tekmira parent protiva willing guarantee protiva performance under this agreement upon term subject condition forth this agreement style margin margin bottom text indent font size font family time roman therefore consideration mutual covenant contained herein other good valuable consideration receipt which hereby acknowledged dicerna protiva enter into this agreement effective effective date style page break before always size style color width align center style margin margin bottom font size font family time roman align center article definition style margin margin bottom text indent font size font family time roman general when used this agreement each following term whether used singular plural shall have meaning forth this article style margin margin bottom text indent font size font family time roman affiliate mean with respect person corporation company partnership joint venture firm which control controlled under common control with such person purpose foregoing sentence control mean nbsp case corporate entity direct indirect ownership least fifty percent nbsp stock share having right vote election director nbsp case corporate entity direct indirect ownership least fifty percent nbsp equity interest with power direct management policy such corporate entity style margin margin bottom text indent font size font family time roman agreement meaning forth introductory paragraph style margin margin bottom text indent font size font family time roman applicable mean applicable statute rule regulation guideline guidance ordinance order decree writ judicial administrative decision like nation government state other political subdivision thereof entity exercising executive judicial regulatory administrative function pertaining government including governmental authority tribunal arbitrator competent jurisdiction trade organization whose regulation have force style margin margin bottom text indent font size font family time roman arbitrator meaning forth section nbsp style margin margin bottom text indent font size font family time roman mean contract manufacturing organization style margin margin bottom text indent font size font family time roman code meaning forth section nbsp style margin margin bottom text indent font size font family time roman commercialize commercialization mean excluding manufacturing activity directed marketing promoting distributing importing having imported exporting having exported selling having sold product service including subject term this agreement having third party conduct such activity behalf person receiving right commercialize style margin margin bottom text indent font size font family time roman commercially reasonable effort mean effort resource that would reasonably used including promptness with which such effort resource would applied similarly sized company within biopharmaceutical industry pharmaceutical clinical development manufacture commercialization pharmaceutical product similar market profit potential similar stage development product life compared product other activity which this term applies style margin margin bottom text indent font size font family time roman confidential information mean confidential information confidential material patentable otherwise party disclosed behalf such party other party before after effective date connection with discussion negotiation pertaining course performing this agreement supply agreement quality agreement including term such agreement including chemical substance equipment data report know source supply patent positioning business plan also each party proprietary confidential information third party possession such party under obligation confidentiality whether related making using selling product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman control control controlled mean with respect licensed intellectual property possession whether ownership license other than pursuant this agreement ability protiva tekmira applicable grant access license sublicense licensed intellectual property provided herein style margin margin bottom text indent font size font family time roman cover cover covered mean with respect product that ownership license sublicense granted under valid claim protiva patent development manufacture commercialization with respect product would infringe such patent such patent patent application would infringe patent issued from such patent application based claim pending patent application moment determination cover cover covered being made style margin margin bottom text indent font size font family time roman mean clinical trial application filed with national competent authority member state regulatory approval clinical trial product including amendment supplement application style margin margin bottom text indent font size font family time roman develop developing development mean manufacturing activity study required develop product service regulatory approval commercialization including subject term this agreement having third party conduct such activity study behalf person receiving right develop style margin margin bottom text indent font size font family time roman dicerna meaning forth preamble style margin margin bottom text indent font size font family time roman dicerna indemnitees meaning forth section nbsp style margin margin bottom text indent font size font family time roman directed mean respect product initial development program initial initial submitted with regulatory authority regulatory approval respect such product intended treatment style margin margin bottom text indent font size font family time roman disclosing party mean party that discloses confidential information style margin margin bottom text indent font size font family time roman discover discovering discovery mean research discovery activity respect product service including subject term this agreement having third party conduct such activity behalf person receiving right discover style margin margin bottom text indent font size font family time roman dispute meaning forth section nbsp style margin margin bottom text indent font size font family time roman mean protiva drug master file filed with regulatory authority covering manufacture product style margin margin bottom text indent font size font family time roman effective date meaning forth introductory paragraph style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman mean european medicine agency body european union established regulation european parliament council march nbsp successor agency thereof performing similar function style margin margin bottom text indent font size font family time roman enforcement cost meaning forth section nbsp style margin margin bottom text indent font size font family time roman enforcing party meaning forth section nbsp style margin margin bottom text indent font size font family time roman european union mean european union which following entry into force treaty lisbon december nbsp replaced succeeded european community established treaty rome signed march nbsp style margin margin bottom text indent font size font family time roman excluded target mean style margin margin bottom text indent font size font family time roman mean food drug administration united state department health human service successor agency thereof performing similar function style margin margin bottom text indent font size font family time roman field mean treatment prevention diagnosis nbsp human disease other medical disorder nbsp animal excluding fish arthropod disease other medical disorder provided however that term field shall include product directed excluded target style margin margin bottom text indent font size font family time roman final inventory meaning forth section nbsp style margin margin bottom text indent font size font family time roman first commercial sale mean first bona fide sale product sublicensee third party length transaction after regulatory approval response submission style margin margin bottom text indent font size font family time roman gaap mean united state generally accepted accounting principle effect from time time consistently applied style margin margin bottom text indent font size font family time roman governmental authority mean united state supra national foreign federal state local provincial municipal government governmental regulatory administrative authority agency body branch bureau instrumentality commission court tribunal judicial arbitral body having relevant jurisdiction over subject matter including regulatory authority style margin margin bottom text indent font size font family time roman mean hydroxyacid oxidase glycolate oxidase gene transcribing protein hydroxyacid oxidase style margin margin bottom text indent font size font family time roman mean with respect product investigational drug application filed with respect product described regulation including amendment supplement application equivalent filing with regulatory authority outside united state style margin margin bottom text indent font size font family time roman indemnified party meaning forth section nbsp style margin margin bottom text indent font size font family time roman indemnifying party meaning forth section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom text indent font size font family time roman insolvent party meaning forth section nbsp style margin margin bottom text indent font size font family time roman joint patent meaning forth supply agreement style margin margin bottom text indent font size font family time roman know mean biological material other tangible material information data invention practice method methodology protocol formula formulation oligonucleotide sequence knowledge trade secret process assay skill experience technique result experimentation testing patentable otherwise style margin margin bottom text indent font size font family time roman licensed intellectual property mean protiva intellectual property tekmira patent style margin margin bottom text indent font size font family time roman lipid nanoparticles mean lipid particle plus minus encapsulated drug lipid component lipid particle formulation comprising lipid particle method manufacturing lipid particle style margin margin bottom text indent font size font family time roman technology mean intellectual property other than protiva patent covering nucleic acid delivery technology directed nbsp composition matter lipid nanoparticles nbsp method lipid nanoparticles nbsp method manufacturing lipid nanoparticles plus minus encapsulated drug each case controlled protiva style margin margin bottom text indent font size font family time roman loss meaning forth section nbsp style margin margin bottom text indent font size font family time roman mean marketing authorization application amendment supplement thereto product filed with national competent authority member state including document data other information concerning product that necessary obtaining regulatory approval place product market member state style margin margin bottom text indent font size font family time roman manufacture manufacturing mean with respect lipid nanoparticle product activity associated with production manufacture testing fill finish packaging labeling releasing processing such material product including having third party conduct such activity behalf person having right manufacture style margin margin bottom text indent font size font family time roman meaning forth recital style margin margin bottom text indent font size font family time roman milestone payment meaning forth section nbsp style margin margin bottom text indent font size font family time roman mean drug application amendment supplement thereto product filed with including document data other information concerning product that necessary gaining regulatory approval market sell product united state style margin margin bottom text indent font size font family time roman sale style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman york court meaning forth section nbsp style margin margin bottom text indent font size font family time roman patent infringement action meaning forth section nbsp style margin margin bottom text indent font size font family time roman party mean either dicerna protiva where specified tekmira party mean dicerna protiva where specified tekmira style margin margin bottom text indent font size font family time roman patent mean patent including reissue extension substitution confirmation registration examination revival supplementary protection certificate patent addition continuation continuation part divisional patent application including provisional application provisional patent application continuation continuation part divisional international application national phase application each case whether foreign country style margin margin bottom text indent font size font family time roman patent infringement action meaning forth section nbsp style margin margin bottom text indent font size font family time roman permitted contractor mean third party contractor consultant that performs activity assigned protiva under this agreement supply agreement under bona fide contract service arrangement which protiva received dicerna prior written consent such consent unreasonably withheld conditioned delayed identity third party scope activity performed such third party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom text indent font size font family time roman person mean individual corporation limited liability company syndicate association trust partnership joint venture unincorporated organization government agency agency instrumentality political subdivision thereof other entity style margin margin bottom text indent font size font family time roman mean primary hyperoxaluria style margin margin bottom text indent font size font family time roman patent infringement action meaning forth section nbsp style margin margin bottom text indent font size font family time roman pivotal trial mean nbsp clinical trial that designed study safety efficacy product help evaluate overall risk benefit intended form primary basis regulatory approval commercialization product more country territory nbsp clinical trial that dicerna affiliate expressly refers press release pivotal trial study nbsp clinical trial that satisfies either following nbsp protocol that clinical trial shall have been reviewed other relevant regulatory authority under procedure reaching agreement design size clinical trial intended form primary basis regulatory approval commercialization product such guidance industry special protocol assessment equivalent guidance issued future comment from other relevant regulatory authority that protocol shall have been incorporated final protocol that clinical trial resolved satisfaction other relevant regulatory authority evidenced further written communication from other relevant regulatory authority nbsp other relevant regulatory authority determined writing that clinical trial considered primary basis regulatory approval commercialization product avoidance doubt clinical trial satisfying requirement sufficient render pivotal trial under this definition shall considered pivotal trial even more than such trial required other regulatory authority regulatory approval commercialization product such trial shall considered initiated later nbsp date that first satisfied requirement this definition nbsp date first dosage patient such trial style margin margin bottom text indent font size font family time roman proceeds meaning forth section nbsp style margin margin bottom text indent font size font family time roman product mean more formulation using licensed intellectual property formulated with more nucleic acid composition including oligonucleotide construct that designed function using interference treatment style margin margin bottom text indent font size font family time roman product composition patent meaning forth supply agreement style margin margin bottom text indent font size font family time roman protiva meaning forth preamble style margin margin bottom text indent font size font family time roman protiva indemnitees meaning forth section nbsp style margin margin bottom text indent font size font family time roman protiva intellectual property mean collectively protiva patent technology confidential information protiva style margin margin bottom text indent font size font family time roman protiva material mean material supplied behalf dicerna affiliate their sublicensee that protiva performance study service style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman protiva patent mean patent controlled protiva that include claim that cover nbsp composition matter lipid nanoparticles nbsp method lipid nanoparticles nbsp method manufacturing lipid nanoparticles plus minus encapsulated drug each case that useful necessary development manufacture commercialization product otherwise cover product including patent listed exhibit excluding patent listed exhibit joint patent style margin margin bottom text indent font size font family time roman quality agreement mean quality agreement dated date hereof between party style margin margin bottom text indent font size font family time roman receiving party mean party that receives confidential information other party style margin margin bottom text indent font size font family time roman record retention period meaning forth section nbsp style margin margin bottom text indent font size font family time roman regulatory approval mean registration license approval authorization from regulatory authority required development manufacture commercialization product regulatory jurisdiction anywhere world style margin margin bottom text indent font size font family time roman regulatory authority mean federal national multinational state provincial local regulatory agency department bureau other governmental entity anywhere world with authority over development manufacture commercialization product under this agreement term regulatory authority includes european commission relevant national competent authority member state style margin margin bottom text indent font size font family time roman royalty meaning forth section nbsp style margin margin bottom text indent font size font family time roman royalty payment term mean product country country basis term beginning effective date ending later nbsp last expire valid claim royalty term patent infringed such product such country nbsp expiration data exclusivity granted regulatory authority such country respect such product nbsp tenth nbsp anniversary first commercial sale such product such country style margin margin bottom text indent font size font family time roman royalty term patent mean nbsp protiva patent tekmira patent provided such patent have been identified dicerna writing time during term protiva provided dicerna with copy thereof nbsp subject section nbsp supply agreement product composition patent style margin margin bottom text indent font size font family time roman service meaning forth supply agreement style margin margin bottom text indent font size font family time roman solvent party meaning forth section nbsp style margin margin bottom text indent font size font family time roman study meaning forth style margin margin bottom text indent font size font family time roman sublicense agreement meaning forth section nbsp style margin margin bottom text indent font size font family time roman sublicensee mean third party whom dicerna granted sublicense sublicense agreement pursuant term hereof style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman supply agreement mean development supply agreement dated date hereof between party style margin margin bottom text indent font size font family time roman tekmira patent mean patent controlled tekmira that include claim that cover nbsp composition matter lipid nanoparticles nbsp method lipid nanoparticles that useful necessary development manufacture commercialization product otherwise cover product including patent listed exhibit excluding patent listed exhibit nbsp method manufacturing lipid nanoparticles plus minus encapsulated drug style margin margin bottom text indent font size font family time roman term mean term described section nbsp style margin margin bottom text indent font size font family time roman territory mean worldwide style margin margin bottom text indent font size font family time roman third party mean person other than protiva dicerna their respective affiliate style margin margin bottom text indent font size font family time roman third party claim meaning forth section nbsp style margin margin bottom text indent font size font family time roman valid claim mean claim nbsp issued unexpired protiva patent tekmira patent product composition patent which claim been revoked held unenforceable unpatentable invalid decision court other governmental agency competent jurisdiction which appealable been appealed within time allowed appeal which been abandoned disclaimed denied admitted invalid unenforceable through reissue examination disclaimer otherwise nbsp patent application that protiva patent tekmira patent product composition patent that been pending more than nbsp year after original priority date said application that been cancelled withdrawn abandoned finally rejected administrative agency action which appealable been appealed within time allowed appeal style margin margin bottom text indent font size font family time roman interpretation style margin margin bottom text indent font size font family time roman word such herein hereinafter hereof hereunder refer this agreement whole merely section paragraph clause which such word appear unless context otherwise requires enumerative reference section paragraph clause exhibit without reference explicit agreement document exhibit refer this agreement exhibit attached this agreement applicable singular shall include plural each masculine feminine neuter reference shall include refer also others unless context otherwise requires word include includes including deemed followed without limitation word similar import except where context otherwise requires word used inclusive sense dollar amount expressed dollar style margin margin bottom text indent font size font family time roman event direct conflict between this agreement supply agreement provision this agreement shall prevail provided however that either this agreement supply agreement expressly contemplates such conflict term such agreement shall control style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom font size font family time roman align center article license grant related right style margin margin bottom text indent font size font family time roman license grant dicerna style margin margin bottom text indent font size font family time roman protiva hereby grant dicerna dicerna hereby accepts worldwide sublicensable subject section nbsp irrevocable except forth article viii perpetual subject article viii right license under protiva intellectual property including patent listed exhibit develop manufacture commercialize product that both nbsp directed treatment nbsp field style margin margin bottom text indent font size font family time roman tekmira hereby grant dicerna dicerna hereby accepts worldwide sublicensable subject section nbsp irrevocable except forth article viii perpetual subject article viii right license under tekmira patent including patent listed exhibit develop manufacture commercialize product that both nbsp directed treatment nbsp field style margin margin bottom text indent font size font family time roman license section exclusive even protiva tekmira except with respect license right granted protiva tekmira licensed intellectual property prior effective date forth exhibit style margin margin bottom text indent font size font family time roman sublicensing style margin margin bottom text indent font size font family time roman dicerna grant written sublicenses each sublicense agreement licensed intellectual property subject section nbsp solely develop manufacture commercialize product solely directed treatment field including cmos provided however that sublicense granted dicerna shall subject except forth below subordinate term condition this agreement shall contain term condition consistent with those this agreement dicerna shall assume full responsibility performance obligation observance term herein under license granted dicerna becomes aware material breach sublicense agreement sublicensee dicerna shall promptly notify protiva particular same take commercially reasonable effort enforce term such sublicense agreement sublicense agreement shall provide that sublicensee only confidential information protiva accordance with term this agreement applicable dicerna such confidential information subject provision least stringent those forth article dicerna shall commercially reasonable effort make protiva express third party beneficiary each agreement defined supply agreement protiva shall express third party beneficiary other sublicense agreement including provision related disclosure protiva confidential information upon expiration termination this agreement provided sublicensee good standing contributed breach other circumstance that termination such sublicense agreement will remain full force effect dicerna will required until expiration termination each sublicense agreement nbsp remit protiva royalty other payment dicerna receives from sublicensee regarding sale other disposition product nbsp enforce term sublicense agreement direction expense protiva style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman unless otherwise provided this agreement dicerna shall notify protiva within nbsp after execution sublicense agreement provide copy fully executed sublicense agreement protiva within same time which shall treated confidential information dicerna under article dicerna redact financial other competitively sensitive information from sublicense agreement prior disclosure protiva style margin margin bottom text indent font size font family time roman grant back dicerna agrees grant hereby grant nbsp protiva exclusive royalty bearing sublicensable right license under licensed intellectual property solely purpose performing obligation under this agreement supply agreement quality agreement nbsp tekmira exclusive royalty bearing sublicensable right license under tekmira patent solely purpose performing obligation under this agreement supply agreement quality agreement style margin margin bottom text indent font size font family time roman retained right style margin margin bottom text indent font size font family time roman each protiva tekmira expressly retains right expressly granted dicerna under this article otherwise under this agreement under supply agreement nothing section nbsp limit protiva ability perform obligation under this agreement supply agreement style margin margin bottom text indent font size font family time roman notwithstanding anything contrary contained herein subject term forth supply agreement including section nbsp supply agreement nbsp neither tekmira protiva granting dicerna license research develop otherwise improve upon lipid nanoparticles based tekmira patent protiva intellectual property confidential information received from tekmira protiva clarity dicerna otherwise research develop improve upon lipid nanoparticles without tekmira patent protiva intellectual property confidential information received from tekmira protiva nbsp license provided from either party other know except necessary useful party fulfill obligation regulatory authority subject penultimate sentence section nbsp necessary party perform activity required expressly permitted under this agreement supply agreement quality agreement with respect product style margin margin bottom text indent font size font family time roman right bankruptcy license right license granted under pursuant this agreement protiva dicerna shall otherwise deemed purpose section nbsp united state bankruptcy code code license right intellectual property defined under section nbsp code dicerna licensee such right under this agreement shall retain fully exercise right election under code that upon commencement bankruptcy proceeding against protiva affiliate protiva that owns control protiva intellectual property tekmira patent under code dicerna shall entitled complete duplicate complete access dicerna deems appropriate such intellectual property embodiment such intellectual property style margin margin bottom text indent font size font family time roman contractor notwithstanding section protiva utilize permitted contractor perform obligation accordance with this agreement supply style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom font size font family time roman agreement provided that protiva shall share dicerna confidential information with permitted contractor unless protiva permitted contractor shall have executed binding agreement which contains nbsp obligation confidentiality invention assignment consistent with least protective dicerna right provision this agreement nbsp other reasonable customary term condition enable protiva comply with obligation under this agreement supply agreement style margin margin bottom font size font family time roman align center article financial provision style margin margin bottom text indent font size font family time roman upfront payment milestone payment style margin margin bottom text indent font size font family time roman before third style font size vertical align nbsp following effective date dicerna shall make time fully earned refundable creditable payment protiva amount partial consideration right granted under this agreement style margin margin bottom text indent font size font family time roman subject term condition this agreement dicerna shall make following fully earned refundable creditable milestone payment upon achievement specified milestone with respect product each milestone payment style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman milestone event valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid milestone nbsp valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom text indent font size font family time roman there more than product development commercialization same time dicerna shall obligated make each milestone payment every product that achieves milestone forth above there more than product that satisfies applicable milestone event more than milestone payment milestone event shall owed dicerna protiva provided however that first milestone event section nbsp been reached product initiation first pivotal trial milestone payment made such product ultimately obtain regulatory approval united state market market member state then subsequent product there will milestone payment upon initiation first pivotal trial that subsequent product style margin margin bottom text indent font size font family time roman dicerna shall good faith determining whether designate clinical trial product pivotal trial shall manipulate structure clinical trial product that would otherwise meet definition pivotal trial such manner avoid meeting such definition purpose delaying payment applicable milestone payment style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom text indent font size font family time roman royalty payment style margin margin bottom text indent font size font family time roman addition payment forth section nbsp during royalty payment term dicerna shall protiva following royalty amount with respect sale product royalty style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom colspan nowrap align center style border bottom solid style margin margin bottom font size font family time roman align center royalty table valign bottom nbsp style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman sale valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid royalty percent nbsp nbsp nbsp sale valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman cumulative worldwide sale than valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman cumulative worldwide sale equal exceeding than valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman cumulative worldwide sale equal exceeding valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom text indent font size font family time roman clarity application royalty tier above royalty table will progressive meaning that royalty percentage each tier only applies sale that tier retroactively prior sale lower tier style margin margin bottom text indent font size font family time roman royalty offset shall apply third party owed royalty dicerna adjuvant additional active substance royalty inclusive royalty owed protiva third party intellectual property licensed dicerna under this agreement which third party royalty exclusively obligation protiva style margin margin bottom text indent font size font family time roman royalty report expense report record audit style margin margin bottom text indent font size font family time roman within after each calendar quarter during royalty payment term until calendar quarter after which dicerna affiliate sublicensees longer selling product dicerna shall provide protiva written report electronic form that includes each calendar quarter nbsp gross invoiced sale product sold during such quarter nbsp sale product nbsp calculated amount royalty owed dicerna pursuant section nbsp respect sale product reasonably requested protiva dicerna will also provide binding estimate sale royalty after calendar quarter prior delivery written report style margin margin bottom text indent font size font family time roman until fifth style font size vertical align nbsp anniversary date book record created such longer period required applicable record retention period dicerna shall style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom font size font family time roman maintain retain complete accurate book account record covering transaction relating payment amount that under section nbsp this agreement upon reasonable advance notice protiva least nbsp dicerna shall make such book record available inspection audit protiva authorized representative which shall national certified public accounting firm designated protiva subject reasonable precaution protect confidential information dicerna protiva audit dicerna book record more than once month period audit must conducted during normal business hour dicerna conducted manner minimize impact normal operation dicerna accounting firm conducting such audit must provide report finding audit both party only identify such report whether amount royalty paid correct actual amount royalty payable disclose other confidential information dicerna auditor report other information disclosed auditor generated auditor such audit will confidential information dicerna protiva shall cost such audit unless discovers that dicerna underreported aggregate sale during year record retention period amount nbsp more which case cost such audit shall borne dicerna audit reveals underpayment overpayment party responsible making payment shall promptly other party amount underpayment overpayment discovered unpaid under this section nbsp subject section nbsp style margin margin bottom text indent font size font family time roman payment procedure style margin margin bottom text indent font size font family time roman remittance payment under this article shall made mean wire transfer immediately available fund bank account designated advance writing protiva amount payable protiva under this agreement shall paid united state dollar those case which amount united state dollar calculated based more currency other than united state dollar such amount shall converted into united state dollar using spot exchange rate relevant currency date applicable transaction such exchange rate published wall street journal comparable publication available style margin margin bottom text indent font size font family time roman milestone payment owed pursuant section nbsp shall paid dicerna protiva within after occurrence event triggering payment such milestone payment style margin margin bottom text indent font size font family time roman royalty shall accrue accordance with section nbsp during applicable royalty payment term royalty obligation that accrue during calendar quarter shall paid within after such quarter style margin margin bottom text indent font size font family time roman payment from party other party under this article that paid date such payment shall bear interest from date such unpaid payment until paid full lesser nbsp nbsp month nbsp highest amount interest permitted applicable foregoing interest shall addition other remedy that either party have pursuant this agreement style margin margin bottom text indent font size font family time roman protiva solely responsible sale excise value added service consumption other similar that assessed connection with payment hereunder style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom font size font family time roman shall either such payment directly reimburse dicerna same withholding other that dicerna affiliate required applicable withhold behalf protiva deducted from such payment paid appropriate authority contemporaneously with remittance protiva provided that nbsp dicerna promptly furnishes protiva proper evidence paid nbsp dicerna cooperates with furnishes protiva appropriate document secure application most favorable rate withholding under applicable exemption from such withholding payment applicable dicerna protiva shall commercially reasonable effort cooperate minimize such assessment extent permitted applicable style margin margin bottom text indent font size font family time roman term payment following expiry royalty payment term respect country nbsp license granted dicerna with respect such country become fully paid sublicensable royalty free exclusive subject section nbsp transferable perpetual irrevocable license continuing indefinitely nbsp obligation dicerna royalty with respect sale product such country terminates style margin margin bottom font size font family time roman align center article additional obligation style margin margin bottom text indent font size font family time roman obligation protiva protiva shall itself through affiliate permitted contractor upon dicerna reasonable request commercially reasonable effort assist dicerna obtaining license from third party needed dicerna affiliate exploit technology contemplated this agreement provided that such effort would require protiva make payment such third party style margin margin bottom text indent font size font family time roman obligation dicerna style margin margin bottom text indent font size font family time roman dicerna shall itself through affiliate sublicensees commercially reasonable effort develop commercialize product provided that protiva sole remedy dicerna breach this section nbsp forth section nbsp style margin margin bottom text indent font size font family time roman until earlier nbsp termination this agreement nbsp first commercial sale product dicerna shall directly indirectly license from third party with product drug delivery system competitive with nbsp composition matter lipid nanoparticles nbsp method lipid nanoparticles nbsp method manufacturing lipid nanoparticles plus minus encapsulated drug each case controlled protiva tekmira licensed dicerna hereunder provided however that after such period dicerna license from third party such drug delivery system then sole remedy protiva license grant protiva section nbsp shall thereafter exclusive basis foregoing prohibit dicerna from licensing third party technology intellectual property necessary develop manufacture commercialize product style margin margin bottom text indent font size font family time roman other obligation agreement party style margin margin bottom text indent font size font family time roman each party agrees that from effective date until expiration nbsp year after expiration term this agreement shall except upon express prior written consent other party each instance directly indirectly employ capacity whether full part time employee consultant contractor individual style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman then employed such other party worked capacity related this agreement supply agreement quality agreement this provision shall apply prohibit general solicitation such posting though public medium focused directed specifically personnel other party hiring employing individual hired party response those general solicitation style margin margin bottom text indent font size font family time roman party acknowledge agree that respect product regulatory dossier filed dicerna with regulatory authority regulatory approval granted excluding either case content directed exclusively licensed intellectual property sole exclusively property dicerna style margin margin bottom text indent font size font family time roman party shall cooperate with each other provide reasonable assistance take action that necessary comply with applicable connection with their respective regulatory authority obligation relation product under this agreement addition party shall work together good faith develop such necessary regulatory strategy which required purpose this agreement style margin margin bottom font size font family time roman align center article intellectual property style margin margin bottom text indent font size font family time roman ownership style margin margin bottom text indent font size font family time roman subject license granted protiva herein protiva shall time remain sole exclusive owner protiva intellectual property style margin margin bottom text indent font size font family time roman subject license granted tekmira herein tekmira shall time remain sole exclusive owner tekmira patent including avoidance doubt excluded patent style margin margin bottom text indent font size font family time roman dicerna shall time remain sole exclusive owner dicerna confidential information style margin margin bottom text indent font size font family time roman prosecution maintenance patent protiva shall have sole right responsibility sole discretion sole cost expense file prosecute maintain abandon patent protection territory protiva patent tekmira shall have sole right responsibility sole discretion sole cost expense file prosecute maintain abandon patent protection territory tekmira patent style margin margin bottom text indent font size font family time roman third party infringement protiva patent tekmira patent style margin margin bottom text indent font size font family time roman each party shall commercially reasonable effort promptly report writing other party during term known suspected commercially relevant infringement third party protiva patent tekmira patent covering product which such party becomes aware provide other party with evidence supporting relating such infringement possession style margin margin bottom text indent font size font family time roman protiva shall have sole exclusive right initiate infringement other appropriate suit with respect infringement suspected infringement protiva patent tekmira shall have sole exclusive right initiate infringement other style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman appropriate suit with respect infringement suspected infringement tekmira patent each case respect infringing activity that directed treatment with product each such suit other action patent infringement action take such other action protiva tekmira sole discretion deems appropriate with respect such infringement suspected infringement protiva tekmira sole cost expense applicable protiva tekmira shall notify dicerna promptly after initiating such patent infringement action that reasonable possibility harming damaging dicerna right license licensed intellectual property style margin margin bottom text indent font size font family time roman protiva shall have first right initiate infringement other appropriate suit with respect infringement suspected infringement protiva patent tekmira shall have first right initiate infringement other appropriate suit with respect infringement suspected infringement tekmira patent each case product that directed treatment each such suit other action patent infringement action together with patent infringement action patent infringement action protiva sole cost expense protiva shall nbsp notify dicerna promptly after initiating such patent infringement action nbsp consult closely with dicerna regarding aspect such patent infringement action permit dicerna have attorney choosing participate such patent infringement action protiva shall enter into settlement compromise connection with patent infringement action that would materially eliminate diminish otherwise modify right title interest dicerna licensed intellectual property that would require payment concession otherwise bind dicerna without dicerna prior written consent which consent shall unreasonably withheld delayed conditioned protiva elect initiate pursue maintain such patent infringement action protiva shall provide dicerna with prompt written notice same thereafter dicerna will have right obligation initiate pursue maintain patent infringement action dicerna deems appropriate with respect such infringement suspected infringement dicerna sole cost expense thereafter dicerna shall consult closely with protiva regarding aspect such patent infringement action permit protiva have attorney choosing participate such patent infringement action dicerna shall enter into settlement compromise connection with patent infringement action that would materially eliminate diminish otherwise modify right title interest protiva tekmira licensed intellectual property that would require payment concession otherwise bind protiva without protiva prior written consent which consent shall unreasonably withheld delayed conditioned style margin margin bottom text indent font size font family time roman upon request party bringing patent infringement action under this section nbsp enforcing party other party shall cooperate with enforcing party such patent infringement action including joining such patent infringement action party with enforcing party necessary required applicable enforcing party requested join party patent infringement action represented cost enforcing party counsel mutually agreed party style margin margin bottom text indent font size font family time roman party shall share proceeds from patent infringement action under this section nbsp including settlement thereof proceeds follows style margin margin bottom text indent font size font family time roman first cost expense including legal that incurred enforcing party part preparation patent infringement action including cost expense enforcing party reimbursed enforcing party accordance with this section enforcement cost style margin margin bottom text indent font size font family time roman remainder proceeds will treated sale with protiva receiving royalty such remainder proceeds accordance with section nbsp dicerna receiving rest remainder proceeds style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman with respect infringement suspected infringement protiva patent tekmira patent that would result action that could reasonably considered both patent infringement action patent infringement action protiva shall have first right initiate infringement other appropriate suit subject section nbsp protiva elect initiate pursue maintain such patent infringement action protiva shall provide dicerna with prompt written notice same thereafter dicerna will have right obligation initiate pursue maintain only claim that would form basis patent infringement action dicerna sole cost expense subject section nbsp party will share proceeds from such patent infringement action consistent with section nbsp above after reimbursement each party enforcement cost protiva retains proceeds resulting from infringing activity directed treatment with product proceeds resulting from infringing activity related product directed treatment will shared accordance with section nbsp style margin margin bottom text indent font size font family time roman defense brought third party each party shall promptly notify other party becomes aware claim that dicerna actual sale practice product connection with exercise license under section nbsp infringes misappropriates otherwise violates intellectual property right third party style margin margin bottom font size font family time roman align center article confidential information publicity style margin margin bottom text indent font size font family time roman limitation disclosure with exception information essential regulatory authority filing documentation fulfilled neither party shall obligated disclose other party confidential information related technology protiva shall disclose specific information regarding chemical composition formulation lipid nanoparticles used product purpose filing with regulatory authority provided however that nbsp protiva shall obligated disclose dicerna detail related process which such formulation selected chemistry other lipid used formulation nbsp subject section nbsp protiva discloses confidential information dicerna with regulatory authority dicerna shall disclose such confidential information without protiva prior written consent style margin margin bottom text indent font size font family time roman disclosure confidential information each party agrees that itself affiliate until tenth nbsp anniversary termination expiration this agreement receiving party shall maintain confidential information disclosing party strict confidence shall nbsp disclose confidential information third party without prior written consent disclosing party except disclosure expressly permitted below receiving party affiliate sublicensees each their employee style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman have need know such confidential information purpose exploiting license granted herein otherwise conducting their activity under this agreement nbsp confidential information purpose except those explicitly licensed otherwise authorized permitted this agreement provided that foregoing obligation shall survive with respect confidential information that receiving protection trade secret under applicable long such confidential information continues receive such protection style margin margin bottom text indent font size font family time roman exception obligation this article shall apply with respect portion confidential information that receiving party show competent documented proof nbsp known receiving party affiliate without obligation keep confidential restriction prior disclosure disclosing party nbsp subsequently disclosed receiving party affiliate third party lawfully possession thereof without obligation keep confidential restriction nbsp otherwise becomes generally available public enters public domain either before after disclosed receiving party such public availability result directly indirectly fault improper taking disclosure receiving party affiliate anyone working concert participation with receiving party affiliate nbsp been independently developed employee contractor receiving party affiliate without application confidential information disclosing party notwithstanding foregoing nbsp specific confidential information disclosed disclosing party shall deemed within exception forth nbsp above merely because embraced more general information which more those exception apply nbsp combination information shall deemed within such exception unless combination itself principle operation within public domain nbsp disclosure confidential information regulatory authority shall constitute public disclosure shall remain confidential information after such disclosure even though confidential information within exception described preceding sentence receiving party shall disclose third party that excepted confidential information received from disclosing party style margin margin bottom text indent font size font family time roman permitted protection confidential information disclosing party used receiving party performance obligation under this agreement supply agreement quality agreement including disclosure permitted contractor bound enforceable confidentiality agreement with term consistent with least protective this article otherwise expressly authorized this agreement expressly authorized disclosing party writing confidential information that licensed intellectual property used dicerna subject accordance with provision this agreement supply agreement quality agreement extent applicable dicerna license licensed intellectual property each receiving party shall take step maintain confidentiality disclosing party confidential information that consistent with step take maintain confidentiality confidential information similar value event than commercially reasonable step provided however that nothing this agreement shall deemed eliminate restrict otherwise limit dicerna license such confidential information accordance with term condition this agreement even such result directly indirectly disclosure such confidential information long such disclosure made manner than complies with section nbsp below style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman permitted disclosure receiving party disclose confidential information belonging disclosing party extent only extent such disclosure reasonably necessary following instance nbsp subject proviso below either party hereto order comply with patent applicable including security applicable rule security exchange relevant jurisdiction with judicial process based reasonable advice receiving party counsel such disclosure necessary such compliance nbsp subject proviso below either party hereto connection with prosecuting defending litigation nbsp subject proviso below dicerna sublicensees their sublicensees connection with legal regulatory requirement related development manufacture commercialization product that employ licensed intellectual property such labeling requirement disclosure connection with obtaining regulatory approval like long development manufacture commercialization product been performed manner that complies with term condition dicerna license such licensed intellectual property reasonable step taken maintain confidentiality said confidential information even when disclosed legal regulatory purpose provided however that with respect clause nbsp nbsp where legally permissible nbsp receiving party shall notify disclosing party receiving party intent make disclosure pursuant thereto sufficiently prior making such disclosure allow disclosing party adequate time take whatever action deem appropriate protect confidentiality information disclosed including seeking protective order injunctive relief nbsp consistent with applicable disclosing party shall have right suggest reasonable change disclosure protect interest receiving party shall unreasonably refuse include such change disclosure style margin margin bottom text indent font size font family time roman press release each party shall publicize execution this agreement issuing respective press release attached hereto exhibit after such initial press release neither party shall issue press release public announcement relating other party collaboration activity undertaken pursuant this agreement supply agreement without prior written approval other party which approval shall unreasonably withheld delayed conditioned provided however that nbsp either party nbsp issue press release public announcement required applicable nbsp nothing foregoing will prevent dicerna from issuing press release public announcement regarding product that reference protiva tekmira technology except that dicerna shall without protiva consent acknowledge that protiva licensed dicerna technology protiva patent respect such product except otherwise provided herein each party agrees name trademark service mark design registered other party affiliate publicity promotional advertising material without prior written approval other party style margin margin bottom font size font family time roman align center article indemnification insurance style margin margin bottom text indent font size font family time roman protiva indemnification protiva agrees indemnify dicerna affiliate their respective agent director officer employee representative successor style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman permitted assigns dicerna indemnitees against hold each them harmless from loss cost damage expense loss actually incurred suffered dicerna indemnitee extent arising connection with claim suit demand investigation proceeding brought third party based nbsp breach representation warranty covenant protiva under this agreement nbsp protiva affiliate permitted contractor gross negligence willful misconduct violation applicable foregoing indemnification shall apply extent that loss dicerna affiliate sublicensees gross negligence willful misconduct style margin margin bottom text indent font size font family time roman dicerna indemnification dicerna agrees indemnify protiva affiliate their respective agent director officer employee representative successor permitted assigns protiva indemnitees against hold each them harmless from loss actually incurred suffered protiva indemnitee extent arising connection with claim suit demand investigation proceeding brought third party based nbsp breach representation warranty covenant dicerna under this agreement nbsp dicerna affiliate sublicensees gross negligence willful misconduct violation applicable nbsp product recall product liability similar claim based development commercialization product except extent that protiva required indemnify dicerna indemnitees such loss pursuant supply agreement foregoing indemnification obligation shall apply extent that loss protiva affiliate permitted contractor gross negligence willful misconduct style margin margin bottom text indent font size font family time roman tender defense counsel person indemnified party seeking indemnification under this article agrees give prompt notice writing other party indemnifying party assertion claim commencement action third party third party claim respect which indemnity sought under this article such notice shall forth reasonable detail such third party claim basis indemnification taking into account information then available indemnified party failure notify indemnifying party shall relieve indemnifying party indemnification hold harmless obligation hereunder except extent such failure shall have materially adversely prejudiced indemnifying party indemnifying party shall entitled participate defense third party claim shall entitled control appoint lead counsel reasonably satisfactory indemnified party such defense written notice indemnified party within nbsp calendar after indemnifying party received notice third party claim each case expense provided however that indemnifying party must commercially reasonable effort conduct defense third party claim manner designed protect right indemnified party otherwise conduct such defense actively diligently thereafter order preserve right this regard indemnifying party shall entitled assume maintain control defense third party claim shall expense counsel retained indemnified party nbsp third party claim relates arises connection with criminal proceeding action indictment allegation nbsp third party claim seek injunction equitable relief against indemnified party affiliate nbsp indemnifying party failed failing prosecute defend vigorously third party claim each indemnified party shall obtain prior written consent indemnifying party such consent unreasonably withheld delayed conditioned before entering into style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom font size font family time roman settlement third party claim notwithstanding foregoing indemnifying party shall entitled enter into approve settlement third party claim without consent indemnified party which withheld sole discretion settlement nbsp expressly unconditionally release applicable indemnified party their affiliate from loss with respect such third party claim nbsp imposes injunctive other equitable relief against indemnified party affiliate nbsp involves admission criminal similar liability nbsp involves monetary damage that fully covered indemnifying party event that indemnifying party fails assume defense third party claim accordance with this section nbsp nbsp indemnified party defend against third party claim manner reasonably deem appropriate nbsp indemnifying party shall remain responsible loss indemnified party result such third party claim circumstance where indemnifying party controlling defense third party claim accordance with this section nbsp indemnified party shall entitled participate defense third party claim employ separate counsel choice such purpose which case expense such separate counsel shall borne such indemnified party notwithstanding anything herein contrary circumstance where there conflict interest that would reasonably make inappropriate under applicable standard professional conduct have common counsel indemnifying party indemnified party indemnified party shall entitled employ separate counsel that reasonably acceptable indemnifying party indemnifying party shall reasonable expense such separate counsel each party shall cooperate cause their respective affiliate cooperate reasonable respect defense prosecution third party claim shall furnish cause furnished such record information testimony attend such conference discovery proceeding hearing trial appeal reasonably requested connection therewith expense indemnifying party style margin margin bottom text indent font size font family time roman insurance each party shall maintain insurance including product liability insurance with respect activity under this agreement regarding product such amount such party customarily maintains with respect similar activity other product each party shall maintain such insurance long continues activity under this agreement supply agreement quality agreement thereafter long such party customarily maintains insurance itself covering similar activity other product notwithstanding foregoing party agree that during such time that tekmira affiliate protiva protiva shall have satisfied obligation under this section nbsp provided covered tekmira existing insurance policy that also satisfy obligation under this section nbsp style margin margin bottom font size font family time roman align center article viii term termination style margin margin bottom text indent font size font family time roman term term this agreement term shall begin effective date unless terminated earlier provided herein shall continue perpetuity style margin margin bottom text indent font size font family time roman termination material breach either party commits material breach material default performance observance obligation under this agreement such breach default continues without cure period after delivery other party written notice reasonably detailing such breach default then style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom font size font family time roman breaching defaulting party shall have right terminate this agreement with immediate effect giving written notice breaching defaulting party party shall retain right remedy equity respect breach hereof style margin margin bottom text indent font size font family time roman termination failure actively develop commercialize protiva reasonably concludes that dicerna failing commercially reasonable effort actively develop commercialize product protiva request from dicerna written confirmation that dicerna affiliate sublicensees actively developing commercializing product following receipt such request dicerna either nbsp fails deliver such written confirmation protiva within nbsp protiva delivery such request nbsp provides such written confirmation thereafter timely diligent manner actually commercially reasonable effort actively develop commercialize product protiva terminate this agreement immediately written notice dicerna style margin margin bottom text indent font size font family time roman challenge protiva patent tekmira patent dicerna affiliate sublicensees directly voluntarily commences participates action proceeding including patent opposition examination proceeding otherwise asserts writing protiva affiliate patent trademark office claim challenging denying validity protiva patent tekmira patent protiva tekmira applicable shall have right give notice dicerna which notice must given within nbsp after protiva general counsel first learns foregoing that license granted protiva dicerna hereunder such protiva patent tekmira dicerna hereunder such tekmira patent shall terminate nbsp following dicerna receipt such notice unless dicerna affiliate sublicensees applicable withdraws cause withdrawn such challenge within such period such license such protiva patent tekmira patent applicable shall terminate provided that such action proceeding assertion made sublicensee license shall only terminate with respect sublicense granted such sublicensee neither dicerna affiliate sublicensee their employee participating appearing such action proceeding claim result receiving subpoena other court order requiring such participation appearance will give rise right protiva terminate forth this section nbsp style margin margin bottom text indent font size font family time roman right bankruptcy each party insolvent party shall promptly notify other party solvent party writing upon initiation proceeding bankruptcy reorganization dissolution liquidation arrangement appointment receiver trustee take possession asset insolvent party similar proceeding under release creditor against insolvent party insolvent party shall make general assignment benefit creditor extent permitted applicable applicable circumstance described above shall have continued nbsp undismissed unstayed unbonded undischarged solvent party terminate this agreement upon written notice insolvent party time protiva insolvent party right remedy granted dicerna solvent party pursuant this section nbsp shall addition lieu dicerna right remedy under section nbsp above style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom text indent font size font family time roman consequence termination survival style margin margin bottom text indent font size font family time roman event this agreement properly terminated accordance with term then dicerna right license under licensed intellectual property shall terminate upon effective date such termination except forth section termination this agreement shall relieve party obligation accruing prior upon such expiration termination provision this section nbsp section nbsp section nbsp article definition article intellectual property article confidential information publicity article indemnification insurance article miscellaneous shall survive expiration termination this agreement style margin margin bottom text indent font size font family time roman effective date termination this agreement supply agreement quality agreement between party shall each automatically terminate subject survival obligation each such agreement provided however that nbsp within nbsp after expiration termination this agreement dicerna will provide protiva with inventory product protiva affiliate their sublicensees including possession control including finished product work process final inventory nbsp period nbsp month after such expiration termination dicerna will have right have cmos complete manufacture work process final inventory sell final inventory including product created from completed work process accordance with term this agreement including section nbsp style margin margin bottom text indent font size font family time roman after expiration termination this agreement dicerna shall have further obligation payment protiva under this agreement including milestone payment except royalty payment obligation accordance with section nbsp related dicerna sale product sold prior date termination sale final inventory accordance with section nbsp style margin margin bottom text indent font size font family time roman remedy party acknowledge agree that event breach threatened breach either party this agreement which shall have adequate remedy other party suffer irreparable damage accordingly entitled injunctive other equitable remedy prevent restrain such breach threatened breach addition other remedy they might have equity event breach threatened breach party such provision other party shall authorized entitled seek from court competent jurisdiction injunctive relief whether preliminary permanent arising from such breach which right shall cumulative addition other right remedy which other party entitled equity style margin margin bottom font size font family time roman align center article miscellaneous style margin margin bottom text indent font size font family time roman representation warranty style margin margin bottom text indent font size font family time roman mutual representation warranty protiva dicerna style margin margin bottom text indent font size font family time roman each party hereby represents warrant other party effective date that style margin margin bottom text indent font size font family time roman duly organized validly existing under jurisdiction incorporation formation necessary power authority conduct business manner which currently being conducted asset manner which asset currently owned used enter into perform obligation under this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom text indent font size font family time roman execution delivery performance this agreement been duly authorized necessary action part such party board director other governing body consent approval order authorization registration declaration filing with third party governmental authority necessary execution delivery performance this agreement style margin margin bottom text indent font size font family time roman this agreement constitutes legal valid binding obligation such party enforceable against accordance with term subject nbsp applicable general application relating bankruptcy insolvency relief debtor nbsp applicable governing specific performance injunctive relief other equitable remedy style margin margin bottom text indent font size font family time roman neither affiliate their employee have ever been nbsp convicted crime which person debarred under section nbsp generic drug enforcement under section nbsp nbsp sanctioned suspended excluded otherwise ineligible participate federal health care program including medicare medicaid federal procurement procurement program time this representation warranty longer accurate protiva dicerna case shall immediately notify other such fact style margin margin bottom text indent font size font family time roman protiva representation warranty covenant protiva hereby represents warrant covenant dicerna that style margin margin bottom text indent font size font family time roman protiva shall perform obligation herein compliance with applicable style margin margin bottom text indent font size font family time roman effective date protiva actual knowledge that manufacture sale import protiva intellectual property technology including used product infringes misappropriates otherwise violates issued patent other intellectual property right third party anywhere territory style margin margin bottom text indent font size font family time roman effective date affiliate protiva tekmira other than protiva tekmira control including joint ownership intellectual property right relevant useful development manufacture commercialization product directed treatment style margin margin bottom text indent font size font family time roman neither protiva affiliate assigned transferred conveyed otherwise encumbered during term will assign transfer convey otherwise encumber right title interest patent confidential information other intellectual property either owned exclusively licensed protiva effective date manner that conflict with right granted dicerna hereunder subject only exclusive license granted protiva prior effective date forth exhibit none exclusive license granted protiva prior effective date forth exhibit conflict with right granted dicerna hereunder style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman effective date except grant license right forth section nbsp tekmira party this agreement supply agreement sole purpose providing representation warranty covenant forth this section nbsp style margin margin bottom text indent font size font family time roman each country jurisdiction which protiva control protiva patent effective date exhibit list protiva patent such country jurisdiction with latest twenty year expiration date calculated from earliest filed provisional application from which benefit priority claimed protiva patent such country jurisdiction style margin margin bottom text indent font size font family time roman protiva shall file patent application country jurisdiction predominant purpose extending duration royalty payment term style margin margin bottom text indent font size font family time roman tekmira representation warranty covenant tekmira hereby represents warrant covenant dicerna that style margin margin bottom text indent font size font family time roman effective date duly organized validly existing under jurisdiction incorporation formation necessary power authority conduct business manner which currently being conducted asset manner which asset currently owned used enter into perform obligation under this agreement style margin margin bottom text indent font size font family time roman effective date execution delivery performance this agreement been duly authorized necessary action part tekmira board director consent approval order authorization registration declaration filing with third party governmental authority necessary execution delivery performance this agreement style margin margin bottom text indent font size font family time roman effective date tekmira actual knowledge that manufacture sale import tekmira patent including used product infringes misappropriates otherwise violates issued patent other intellectual property right third party anywhere territory style margin margin bottom text indent font size font family time roman effective date this section nbsp constitutes legal valid binding obligation tekmira enforceable against accordance with term subject nbsp applicable general application relating bankruptcy insolvency relief debtor nbsp applicable governing specific performance injunctive relief other equitable remedy style margin margin bottom text indent font size font family time roman effective date neither affiliate their employee have ever been nbsp convicted crime which person debarred under section nbsp generic drug enforcement under section nbsp nbsp sanctioned suspended excluded otherwise ineligible participate federal health care program including medicare medicaid federal procurement procurement program style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman time representation warranty section nbsp longer accurate tekmira shall promptly notify dicerna such fact style margin margin bottom text indent font size font family time roman neither tekmira affiliate assigned transferred conveyed otherwise encumbered during term will assign transfer convey otherwise encumber right title interest patent owned exclusively licensed tekmira effective date manner that conflict with right granted dicerna hereunder subject only exclusive license granted tekmira prior effective date forth exhibit none exclusive license granted tekmira prior effective date forth exhibit conflict with right granted dicerna hereunder style margin margin bottom text indent font size font family time roman viii tekmira shall cause protiva perform comply with provision this agreement shall remain responsible guarantee performance protiva under this agreement liable dicerna breach this agreement protiva action omission protiva undertaken pursuant this agreement taken tekmira itself style margin margin bottom text indent font size font family time roman each country jurisdiction which tekmira control tekmira patent effective date exhibit list tekmira patent such country jurisdiction with latest twenty year expiration date calculated from earliest filed provisional application from which benefit priority claimed tekmira patent such country jurisdiction style margin margin bottom text indent font size font family time roman tekmira shall file patent application country jurisdiction predominant purpose extending duration royalty payment term style margin margin bottom text indent font size font family time roman warranty disclaimer except otherwise expressly provided this agreement neither party make representation extends warranty condition kind either express implied other party with respect intellectual property product good right other subject matter this agreement hereby disclaims implied condition representation warranty including warranty merchantability fitness particular purpose noninfringement validity patent right with respect foregoing each party hereby disclaims representation warranty that development manufacture commercialization product pursuant this agreement shall successful that particular sale level with respect such product shall achieved style margin margin bottom text indent font size font family time roman force majeure except with respect payment obligation party shall neither held liable responsible other party deemed have defaulted under style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman breached this agreement failure delay fulfilling performing term this agreement extent long such failure delay caused result from cause beyond reasonable control affected party including fire flood embargo power shortage failure whether declared insurrection riot terrorism civil commotion strike lockout other labor disturbance omission delay acting governmental authority other party such affected party promptly begin performing under this agreement once such cause have been removed style margin margin bottom text indent font size font family time roman consequential damage under circumstance will party liable other party with respect this agreement activity contemplated hereby consequential indirect special punitive incidental similar damage whether foreseeable unforeseeable regardless cause action from which they arise even advised possibility such damage occurring notwithstanding foregoing nothing this section intended shall limit restrict indemnification right party damage available party breach confidentiality obligation article style margin margin bottom text indent font size font family time roman assignment neither party shall assign right obligation hereunder without prior written consent other party except nbsp purchaser substantially asset business such party which this agreement relates successor resulting from merger acquisition consolidation similar transaction with such party nbsp affiliate provided however that nbsp such assignment affiliate shall relieve such party obligation herein nbsp each case assigning party shall provide other party with written notice such assignment purported transfer assignment contravention this section nbsp shall option assigning party null void effect this agreement shall binding upon inure benefit party their permitted successor assigns style margin margin bottom text indent font size font family time roman notice style margin margin bottom text indent font size font family time roman notice dicerna shall addressed style margin margin bottom margin left font size font family time roman dicerna pharmaceutical style margin margin bottom margin left font size font family time roman arsenal style margin margin bottom margin left font size font family time roman watertown style margin margin bottom margin left font size font family time roman united state style margin margin bottom margin left font size font family time roman attention president style margin margin bottom text indent font size font family time roman with copy style margin margin bottom margin left font size font family time roman dicerna pharmaceutical style margin margin bottom margin left font size font family time roman arsenal style margin margin bottom margin left font size font family time roman watertown style margin margin bottom margin left font size font family time roman united state style margin margin bottom margin left font size font family time roman attention chief financial officer style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman notice protiva shall addressed style margin margin bottom margin left font size font family time roman protiva pharmaceutical corporation style margin margin bottom margin left font size font family time roman glenlyon parkway style margin margin bottom margin left font size font family time roman burnaby style margin margin bottom margin left font size font family time roman canada style margin margin bottom margin left font size font family time roman attention president nbsp style margin margin bottom margin left font size font family time roman facsimile nbsp style margin margin bottom text indent font size font family time roman notice tekmira shall addressed style margin margin bottom margin left font size font family time roman tekmira pharmaceutical corporation style margin margin bottom margin left font size font family time roman glenlyon parkway style margin margin bottom margin left font size font family time roman burnaby style margin margin bottom margin left font size font family time roman canada style margin margin bottom margin left font size font family time roman attention president nbsp style margin margin bottom margin left font size font family time roman facsimile nbsp style margin margin bottom text indent font size font family time roman each case with copy style margin margin bottom margin left font size font family time roman orrick herrington nbsp sutcliffe style margin margin bottom margin left font size font family time roman west style font size vertical align street style margin margin bottom margin left font size font family time roman york style margin margin bottom margin left font size font family time roman attention king milling style margin margin bottom margin left font size font family time roman facsimile nbsp style margin margin bottom font size font family time roman party hereto change their address giving notice other party manner provided this section nbsp notice required provided term this agreement shall writing shall nbsp sent certified mail return receipt requested postage prepaid nbsp sent reputable international express courier service nbsp sent facsimile transmission with copy regular mail effective date notice shall actual date receipt receiving party style margin margin bottom text indent font size font family time roman independent contractor understood agreed that relationship between party that independent contractor that nothing this agreement shall construed authorization either party agent other party style margin margin bottom text indent font size font family time roman governing dispute resolution arbitration this agreement shall governed interpreted accordance with substantive state york excluding conflict principle style margin margin bottom text indent font size font family time roman party tekmira recognize that bona fide dispute certain matter from time time arise during term that relate party tekmira right obligation hereunder event occurrence dispute party tekmira shall first have such dispute referred their respective executive designated below style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman attempted resolution good faith negotiation within nbsp calendar after such notice received either party tekmira desire pursue arbitration under section nbsp below resolve such dispute unless expressly provided otherwise herein referral such executive under this section nbsp shall mandatory condition precedent said designated executive effective date follows style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign nbsp dicerna valign bottom valign douglas fambrough president style font size height height colspan style font family time roman font size valign nbsp protiva valign bottom valign mark murray president style font size height height colspan style font family time roman font size valign nbsp tekmira valign bottom valign mark murray president table style margin margin bottom font size font family time roman event that they shall unable resolve dispute consensus within such period dispute shall finally settled binding arbitration provided below style margin margin bottom text indent font size font family time roman except expressly otherwise provided this agreement event dispute arising relating interpretation provision this agreement failure either party tekmira perform comply with obligation such party pursuant this agreement breach termination validity hereof dispute such dispute will finally settled arbitration accordance with commercial arbitration rule american arbitration association then force federal arbitration three nbsp arbitrator arbitrator provided that appointed arbitrator shall have appropriate experience pharmaceutical industry dicerna shall appoint arbitrator protiva tekmira collectively shall appoint arbitrator such arbitrator shall jointly appoint third arbitrator party able appoint arbitrator initial arbitrator able appoint third arbitrator within reasonable amount time after initiation such process applicable arbitrator arbitrator will appointed accordance with above identified commercial arbitration rule place arbitration will york york arbitrator must decide dispute accordance with substantive state york arbitrator accepting their appointment undertake conduct process such that award rendered within nbsp month their appointment final binding upon party participating such arbitration judgment rendered arbitrator arbitrator discretion include cost arbitration reasonable attorney reasonable cost expert other witness judgment upon award entered court having jurisdiction application made such court judicial acceptance award order enforcement case period limitation survival period that would otherwise expire between initiation procedure described this section nbsp conclusion such procedure will extended until nbsp following conclusion such procedure this section nbsp prohibit party tekmira from seeking preliminary injunctive relief arbitration from court competent jurisdiction style margin margin bottom text indent font size font family time roman party tekmira consent nbsp exclusive jurisdiction federal court state court state york each case located borough manhattan city york york court nbsp action referenced section nbsp nbsp action arbitration provisional relief status prevent irreparable harm prior appointment arbitrator section nbsp above style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom font size font family time roman exclusive jurisdiction york court action enter enforce arbitral award entered connection with this agreement party tekmira hereby irrevocably waive agree cause their respective affiliate waive right trial jury such action style margin margin bottom text indent font size font family time roman unless agreed party foregoing alternative dispute resolution procedure shall used with respect claim party against another regarding validity infringement misappropriation violation patent copyright trade secret trademark style margin margin bottom text indent font size font family time roman severability event that provision this agreement held court competent jurisdiction unenforceable because invalid conflict with relevant jurisdiction validity remaining provision shall affected right obligation party tekmira shall construed enforced agreement contain particular provision held unenforceable provided that party tekmira shall negotiate good faith modification this agreement with view revising this agreement manner which reflects closely reasonably practicable commercial term this agreement originally signed style margin margin bottom text indent font size font family time roman implied waiver waiver either party tekmira breach default provision this agreement other party tekmira shall construed waiver succeeding breach same other provision shall delay omission part either party tekmira exercise avail itself right power privilege that have hereunder operate waiver right power privilege such party tekmira style margin margin bottom text indent font size font family time roman heading heading article section contained this agreement intended solely convenience ease reference constitute part this agreement have effect interpretation construction style margin margin bottom text indent font size font family time roman entire agreement amendment this agreement along with attachment supply agreement quality agreement contain entire understanding party tekmira with respect subject matter hereof thereof supersede replace previous arrangement understanding whether oral written between party tekmira with respect subject matter hereof thereof this agreement including attachment hereto amended only writing signed each party tekmira style margin margin bottom text indent font size font family time roman waiver rule construction each party tekmira opportunity consult with counsel connection with review drafting negotiation this agreement accordingly rule construction that ambiguity this agreement shall construed against drafting party shall apply style margin margin bottom text indent font size font family time roman third party beneficiary except expressly contemplated herein third party including employee either party tekmira shall have acquire right reason this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman further assurance each party tekmira shall provide such further document instrument required other party tekmira reasonably necessary desirable give effect purpose this agreement carry provision style margin margin bottom text indent font size font family time roman performance affiliate either party more affiliate perform obligation duty hereunder affiliate party expressly granted certain right herein provided that each such affiliate shall bound corresponding obligation such party relevant party shall remain liable hereunder prompt payment performance their respective obligation hereunder style margin margin bottom text indent font size font family time roman counterpart this agreement executed number counterpart original facsimile copy each which shall deemed original which together shall constitute same instrument style margin margin bottom font size font family time roman align center signature page follows style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman witness whereof authorized representative dicerna protiva tekmira have executed delivered this license agreement effective effective date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font family time roman font size valign colspan dicerna pharmaceutical style font size height height colspan style font family time roman font size valign valign bottom valign style margin margin bottom border bottom solid font size font family time roman douglas fambrough style font family time roman font size valign name valign bottom valign douglas fambrough style font family time roman font size valign title valign bottom valign president style font size height colspan style font family time roman font size valign colspan dicerna pharmaceutical style font size height height colspan style font family time roman font size valign valign bottom valign style margin margin bottom border bottom solid font size font family time roman james dentzer style font family time roman font size valign name valign bottom valign james dentzer style font family time roman font size valign title valign bottom valign chief financial officer style font size height colspan style font family time roman font size valign colspan protiva biotherapeutics style font size height height colspan style font family time roman font size valign valign bottom valign style margin margin bottom border bottom solid font size font family time roman cousin style font family time roman font size valign name valign bottom valign cousin style font family time roman font size valign title valign bottom valign style font size height height colspan style font family time roman font size valign valign bottom valign style margin margin bottom border bottom solid font size font family time roman paul brennan style font family time roman font size valign name valign bottom valign paul brennan style font family time roman font size valign title valign bottom valign business development style font size height colspan style font family time roman font size valign colspan tekmira pharmaceutical corporation style font size height height colspan style font family time roman font size valign valign bottom valign style margin margin bottom border bottom solid font size font family time roman cousin style font family time roman font size valign name valign bottom valign cousin style font family time roman font size valign title valign bottom valign style font size height height colspan style font family time roman font size valign valign bottom valign style margin margin bottom border bottom solid font size font family time roman paul brennan style font family time roman font size valign name valign bottom valign paul brennan style font family time roman font size valign title valign bottom valign business development table style margin margin bottom font size font family time roman align center signature page license agreement style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center protiva patent style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width style font family time roman font size valign valign bottom valign valign bottom valign valign bottom valign table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center tekmira patent style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign valign bottom valign table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center excluded patent style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center existing license grant style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman company requested order from commission pursuant rule under security amended granting confidential treatment selected portion accordingly confidential portion have been omitted from this exhibit have been filed separately with commission omitted portion indicated this exhibit with style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center press release style margin margin bottom font size font family time roman dicerna press release attachment style margin margin bottom font size font family time roman protiva press release attachment style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center attachment style margin margin bottom font size font family time roman align center dicerna announces license agreement with tekmira style margin margin bottom font size font family time roman align center advance dicerna development program style margin margin bottom font size font family time roman watertown mass november nbsp dicerna pharmaceutical nasdaq drna leading developer interference rnai therapeutic today announced licensing agreement dicerna tekmira proprietary lipid nanoparticle technology delivery dicerna investigational product candidate primary hyperoxaluria type rare inherited liver disorder that often result kidney failure which there approved therapy style margin margin bottom font size font family time roman this announcement follows successful testing combination with tekmira technology animal model including mouse human primate under agreement dicerna will tekmira million upfront well million potential development milestone single digit royalty future sale style margin margin bottom font size font family time roman tekmira system shown other human clinical study provide potent safe effective delivery hepatocytes liver cell licensing tekmira will streamline development path allows dicerna focus effort oncology pipeline style margin margin bottom font size font family time roman dicerna focused realizing full clinical potential proprietary pipeline highly targeted rnai therapy applying proven technology said douglas fambrough chief executive officer dicerna drawing tekmira extensive deep experience with lipid nanoparticle delivery liver agreement will streamline development path look forward initiating phase trial aiming fill high unmet medical need patient with style margin margin bottom font size font family time roman this agreement validates leadership position rnai delivery underscore significant value bring partner leverage technology said nbsp mark nbsp murray president tekmira technology enabling most advanced application rnai therapeutic clinic excited working with dicerna advancing needed investigational therapeutic treatment style margin margin bottom font size font family time roman about rnai style margin margin bottom font size font family time roman rnai therapeutic have potential treat number human disease silencing disease causing gene discoverer rnai gene silencing mechanism used cell were awarded nobel prize physiology medicine rnai trigger molecule often require delivery technology effective therapeutic style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman about tekmira technology style margin margin bottom font size font family time roman tekmira technology represents most widely adopted delivery technology systemic delivery rnai trigger tekmira platform being utilized multiple clinical trial tekmira partner tekmira technology formerly referred stable nucleic acid lipid particle snalp encapsulates rnai trigger with high efficiency uniform lipid nanoparticles that effective delivering these therapeutic compound disease site tekmira formulation manufactured proprietary method that robust scalable highly reproducible based product have been reviewed multiple regulatory agency clinical trial formulation comprise several lipid component that adjusted suit specific application style margin margin bottom font size font family time roman about primary hyperoxaluria type style margin margin bottom font size font family time roman rare inherited liver disorder that often result severe damage kidney disease fatal unless patient undergoes liver kidney transplant major surgical procedure that often difficult perform lack donor threat organ rejection event successful transplant patient must live rest life immunosuppressant drug which have substantial associated risk currently there approved treatment style margin margin bottom font size font family time roman characterized genetic deficiency liver enzyme alanine glyoxalate aminotransferase which encoded agxt gene deficiency induces overproduction oxalate liver resulting formation crystal calcium oxalate kidney oxalate crystal formation often lead chronic painful case kidney stone subsequent fibrosis scarring which known nephrocalcinosis many patient progress stage renal disease esrd require dialysis transplant aside from having endure frequent dialysis patient with esrd experience build oxalate bone skin heart retina with concomitant debilitating complication while true prevalence primary hyperoxaluria unknown estimated three case million people style font size vertical align fifty percent patient with reach esrd their style font size vertical align style margin margin bottom font size font family time roman about style margin margin bottom font size font family time roman dicerna developing which preclinical development treatment engineered address pathology targeting destroying messenger mrna produced gene implicated pathogenesis encodes glycolate oxidase protein involved producing oxalate reducing oxalate production this approach designed prevent complication preclinical study been shown induce potent long term inhibition significantly reduce level urinary oxalate while demonstrating long term efficacy tolerability animal model style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman about dicerna dicer substrate technology style margin margin bottom font size font family time roman dicerna proprietary rnai molecule known dicer substrate dsirnas called because they processed dicer enzyme which initiation point rnai human cell cytoplasm dicerna discovery approach believed maximize rnai potency because dsirnas structured ideal processing dicer dicer processing enables preferential correct strand dsirna which increase efficacy rnai mechanism well potency dsirna molecule relative other molecule used induce rnai style margin margin bottom font size font family time roman about tekmira style margin margin bottom font size font family time roman tekmira pharmaceutical corporation biopharmaceutical company focused advancing novel rnai therapeutic providing leading lipid nanoparticle delivery technology pharmaceutical partner tekmira been working field nucleic acid delivery over decade broad intellectual property covering delivery technology further information about tekmira found tekmira tekmira based vancouver canada seattle style margin margin bottom font size font family time roman about dicerna style margin margin bottom font size font family time roman dicerna pharmaceutical biopharmaceutical company focused discovery development innovative treatment rare inherited disease involving liver cancer that genetically defined company using proprietary interference rnai technology platform build broad pipeline these therapeutic area both rare disease oncology dicerna pursuing target that have been difficult address using conventional approach where connection between target disease well understood documented company intends discover develop commercialize novel therapeutic either collaboration with pharmaceutical partner style margin margin bottom font size font family time roman cautionary note forward looking statement style margin margin bottom font size font family time roman this press release includes forward looking statement such forward looking statement subject risk uncertainty that could cause actual result differ materially from those expressed implied such statement applicable risk uncertainty include that technology fail deliver liver human being otherwise fail accelerate clinical development that clinical trial demonstrate effectiveness additional risk including those relating dicerna preclinical research clinical development other risk identified under heading risk factor included dicerna most recent form filing other future filing with nbsp forward looking statement contained this press release reflect dicerna current view with respect future event dicerna undertake specifically disclaims obligation update forward looking statement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman reference style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left style font size vertical align nbsp align left valign cochat rumsby primary hyperoxaluria england journal medicine table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left style font size vertical align nbsp align left valign rare kidney stone consortium primary hyperoxaluria available http rarekidneystones hyperoxaluria physician html accessed october nbsp table style margin margin bottom font size font family time roman investor contact style margin margin bottom font size font family time roman westwicke partner style margin margin bottom font size font family time roman yolanda taylor style margin margin bottom font size font family time roman yolanda taylor westwicke style margin margin bottom font size font family time roman medium contact style margin margin bottom font size font family time roman smithsolve style margin margin bottom font size font family time roman alex rees style margin margin bottom font size font family time roman alex vanrees smithsolve style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center attachment style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign immediate release valign bottom valign align right november nbsp table style margin margin bottom font size font family time roman align center tekmira announces licensing collaboration agreement with dicerna style margin margin bottom font size font family time roman align center tekmira enable dicerna candidate style margin margin bottom font size font family time roman vancouver tekmira pharmaceutical corporation nasdaq tkmr leading developer interference rnai therapeutic today announces licensing collaboration agreement with dicerna pharmaceutical tekmira licensed proprietary lipid nanoparticle delivery technology exclusive dicerna primary hyperoxaluria type development program style margin margin bottom font size font family time roman under agreement dicerna will tekmira million upfront payment million aggregate development milestone plus single digit royalty future sale this partnership also includes supply agreement with tekmira providing clinical drug supply regulatory support rapid advancement product candidate style margin margin bottom font size font family time roman agreement announced today follows successful testing demonstration positive result combining tekmira technology with clinical animal model style margin margin bottom font size font family time roman dicerna will tekmira third generation technology delivery dicerna dicer substrate dsirna molecule treatment rare inherited liver disorder that often result kidney failure which there approved therapy style margin margin bottom font size font family time roman this agreement validates leadership position rnai delivery with technology underscore significant value bring partner leverage technology technology enabling most advanced application rnai therapeutic clinic continues excited working with dicerna able advance needed therapeutic treatment said nbsp mark nbsp murray tekmira president style margin margin bottom font size font family time roman core pillar business strategy continue engage partnership where technology improves risk profile accelerates development program collaborator provides meaningful dilutive financing tkmr added nbsp murray style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman dicerna focused realizing full clinical potential proprietary pipeline highly targeted rnai therapy applying proven technology said douglas fambrough chief executive officer dicerna drawing tekmira extensive deep experience with lipid nanoparticle delivery liver agreement will streamline development path look forward initiating phase trial aiming fill high unmet medical need patient with style margin margin bottom font size font family time roman about rnai style margin margin bottom font size font family time roman rnai therapeutic have potential treat number human disease silencing disease causing gene discoverer rnai gene silencing mechanism used cell were awarded nobel prize physiology medicine rnai trigger molecule often require delivery technology effective therapeutic style margin margin bottom font size font family time roman about tekmira technology style margin margin bottom font size font family time roman tekmira belief technology represents most widely adopted delivery technology systemic delivery rnai trigger tekmira platform being utilized multiple clinical trial tekmira partner tekmira technology formerly referred stable nucleic acid lipid particle snalp encapsulates rnai trigger with high efficiency uniform lipid nanoparticles that effective delivering these therapeutic compound disease site tekmira formulation manufactured proprietary method which robust scalable highly reproducible based product have been reviewed multiple regulatory agency clinical trial formulation comprise several lipid component that adjusted suit specific application style margin margin bottom font size font family time roman about primary hyperoxaluria type style margin margin bottom font size font family time roman rare inherited liver disorder that often result severe damage kidney disease fatal unless patient undergoes liver kidney transplant major surgical procedure that often difficult perform lack donor threat organ rejection event successful transplant patient must live rest life immunosuppressant drug which have substantial associated risk currently there approved treatment style margin margin bottom font size font family time roman characterized genetic deficiency liver enzyme alanine glyoxalate aminotransferase which encoded agxt gene deficiency induces overproduction oxalate liver resulting formation crystal calcium oxalate kidney oxalate crystal formation often lead chronic painful case kidney stone subsequent fibrosis scarring which known style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman nephrocalcinosis many patient progress stage renal disease esrd require dialysis transplant aside from having endure frequent dialysis patient with esrd experience build oxalate bone skin heart retina with concomitant debilitating complication while true prevalence primary hyperoxaluria unknown estimated three case million people style font size vertical align fifty percent patient with reach esrd their style font size vertical align style margin margin bottom font size font family time roman about style margin margin bottom font size font family time roman dicerna developing which preclinical development treatment engineered address pathology targeting destroying messenger mrna produced gene implicated pathogenesis encodes glycolate oxidase protein involved producing oxalate reducing oxalate production this approach designed prevent complication preclinical study been shown induce potent long term inhibition significantly reduce level urinary oxalate while demonstrating long term efficacy tolerability animal model style margin margin bottom font size font family time roman about dicerna dicer substrate technology style margin margin bottom font size font family time roman dicerna proprietary rnai molecule known dicer substrate dsirnas called because they processed dicer enzyme which initiation point rnai human cell cytoplasm dicerna discovery approach believed maximize rnai potency because dsirnas structured ideal processing dicer dicer processing enables preferential correct strand dsirna which increase efficacy rnai mechanism well potency dsirna molecule relative other molecule used induce rnai style margin margin bottom font size font family time roman about tekmira style margin margin bottom font size font family time roman tekmira pharmaceutical corporation biopharmaceutical company focused advancing novel rnai therapeutic providing leading lipid nanoparticle delivery technology pharmaceutical partner tekmira been working field nucleic acid delivery over decade broad intellectual property covering delivery technology further information about tekmira found tekmira tekmira based vancouver canada seattle style margin margin bottom font size font family time roman about dicerna style margin margin bottom font size font family time roman dicerna pharmaceutical biopharmaceutical company focused discovery development innovative treatment rare inherited disease involving liver cancer that genetically defined company using proprietary interference rnai technology platform build broad pipeline these therapeutic area both rare disease oncology dicerna pursuing style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman target that have been difficult address using conventional approach where connection between target disease well understood documented company intends discover develop commercialize novel therapeutic either collaboration with pharmaceutical partner style margin margin bottom font size font family time roman forward looking statement information style margin margin bottom font size font family time roman this news release contains forward looking statement forward looking information within meaning applicable security collectively forward looking statement forward looking statement this news release include statement about tekmira strategy future operation clinical trial prospect plan management rnai ribonucleic acid interference product development program licensing collaboration agreement with dicerna upfront development milestone royalty future sale payable dicerna tekmira supply agreement with dicerna initiation phase trial style margin margin bottom font size font family time roman with respect forward looking statement contained this news release tekmira made numerous assumption regarding among other thing status leading rnai delivery technology while tekmira considers these assumption reasonable these assumption inherently subject significant business economic competitive market social uncertainty contingency style margin margin bottom font size font family time roman additionally there known unknown risk factor which could cause tekmira actual result performance achievement materially different from future result performance achievement expressed implied forward looking statement contained herein known risk factor include among others tekmira delivery technology delivery have positive effect treatment tekmira receive milestone payment royalty from dicerna quantum anticipated initiation phase trial occur currently contemplated tekmira product prove effective potent currently believed refuse approve tekmira product place restriction tekmira ability commercialize product tekmira obtain protect intellectual property right operate without infringing intellectual property right others tekmira face competition from other pharmaceutical biotechnology company possibility that other organization have made advancement rnai delivery technology that tekmira aware anticipated clinical clinical trial more costly take longer complete than anticipated never initiated completed generate result that warrant future development tested drug candidate economic capital market condition style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman more complete discussion risk uncertainty facing tekmira appears tekmira annual report form tekmira continuous disclosure filing which available sedar forward looking statement herein qualified their entirety this cautionary statement tekmira disclaims obligation revise update such forward looking statement publicly announce result revision forward looking statement contained herein reflect future result event development except required style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman reference style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left style font size vertical align nbsp align left valign cochat rumsby primary hyperoxaluria england journal medicine table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left style font size vertical align nbsp align left valign rare kidney stone consortium primary hyperoxaluria available http rarekidneystones hyperoxaluria physician html accessed october nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign style margin margin bottom font size font family time roman investor contact style font size margin margin bottom nbsp style margin margin bottom font size font family time roman tekmira style margin margin bottom font size font family time roman julie rezler style font size margin margin bottom nbsp style margin margin bottom font size font family time roman director investor relation style font size margin margin bottom nbsp style margin margin bottom font size font family time roman phone style font size margin margin bottom nbsp style margin margin bottom font size font family time roman email jrezler tekmira valign bottom valign style margin margin bottom font size font family time roman medium contact style font size margin margin bottom nbsp style margin margin bottom font size font family time roman tekmira style margin margin bottom font size font family time roman please direct medium inquiry medium tekmira table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center body html text document